Page last updated: 2024-09-05
lu 135252 and elastin
lu 135252 has been researched along with elastin in 2 studies
Compound Research Comparison
| Studies (lu 135252) | Trials (lu 135252) | Recent Studies (post-2010) (lu 135252) | Studies (elastin) | Trials (elastin) | Recent Studies (post-2010) (elastin) |
|---|---|---|---|---|---|
| 196 | 13 | 14 | 8,308 | 60 | 2,664 |
Research
Studies (2)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Dao, HH; de Champlain, J; deBlois, D; Lemay, J; Moreau, P | 1 |
| Dao, HH; De Champlain, J; Essalihi, R; Graillon, JF; Larivière, R; Moreau, P | 1 |
Other Studies
2 other study(ies) available for lu 135252 and elastin
| Article | Year |
|---|---|
Norepinephrine-induced aortic hyperplasia and extracellular matrix deposition are endothelin-dependent.
Topics: Animals; Aorta; Apoptosis; Arteries; Cell Count; Collagen; Elastin; Endothelin Receptor Antagonists; Endothelins; Extracellular Matrix; Hemodynamics; Hyperplasia; Male; Muscle, Smooth, Vascular; Norepinephrine; Phenylpropionates; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A | 2001 |
Pharmacological prevention and regression of arterial remodeling in a rat model of isolated systolic hypertension.
Topics: Animals; Antihypertensive Agents; Aorta, Thoracic; Arteries; Biphenyl Compounds; Calcinosis; Collagen; Disease Models, Animal; Elastin; Hydrochlorothiazide; Hypertension; Irbesartan; Male; Middle Cerebral Artery; Phenylpropionates; Pyrimidines; Rats; Rats, Wistar; Tetrazoles | 2002 |